Saltoro Capital, LP Acorda Therapeutics Inc Transaction History

Saltoro Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.55 - $1.0 $31,589 - $57,436	-57,436 Reduced 52.78%	51,391 $30,000
Q2 2022 Aug 12, 2022	BUY	$0.3 - $1.67 $28,193 - $156,944	93,979 Added 632.94%	108,827 $14,000
Q4 2021 Feb 04, 2022	BUY	$2.3 - $4.71 $34,150 - $69,934	14,848 New	14,848 $4,000
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.79 $39,826 - $56,775	-11,853 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.61 - $5.23 $42,789 - $61,991	11,853 New	11,853 $57,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Saltoro Capital, LP with notifications on news.